Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis
Evaluation Of The Therapeutic And Dietary Properties Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis
Sponsor: Eurasia Invest Ltd.
This NA trial investigates Non-alcoholic Steatohepatitis and is currently completed. Eurasia Invest Ltd. leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2021 — Mar 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting NA
▶ Show 4 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Sep 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Nov 2018 — Mar 2020 [monthly]
Recruiting NA
-
Oct 2018 — Nov 2018 [monthly]
Recruiting NA
First recorded
Aug 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eurasia Invest Ltd.
- Medical Centre Hospital of the President's Affairs Administration, Republic of Kazakhstan
- Ministry of Education and Science, Republic of Kazakhstan
For direct contact, visit the study record on ClinicalTrials.gov .